• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贝尔格莱德人群中1型强直性肌营养不良症(斯坦纳特病)的生存率和死亡率

Survival and mortality of myotonic dystrophy type 1 (Steinert's disease) in the population of Belgrade.

作者信息

Mladenovic J, Pekmezovic T, Todorovic S, Rakocevic-Stojanovic V, Savic D, Romac S, Apostolski S

机构信息

Clinic for Neurology and Psychiatry for Children and Adolescents, Belgrade, Serbia and Montenegro.

出版信息

Eur J Neurol. 2006 May;13(5):451-4. doi: 10.1111/j.1468-1331.2006.01261.x.

DOI:10.1111/j.1468-1331.2006.01261.x
PMID:16722967
Abstract

The purpose of this investigation was to determine survival and mortality in patients with myotonic dystrophy type 1 (DM1) in the Belgrade population within the period from 1983 to 2002. Data of a number of diagnosed DM1 patients with their demographic, clinical and genetic characteristics were gathered from hospital records in all neurologic institutions in Belgrade for the period 1983-2002. Death certificates were reviewed to determine the cause of death. Survival analysis by life table method and Cox proportional hazard model was performed. Within the observed period, in the population of Belgrade, 15 fatal outcomes among 101 patients with DM1 were registered. Average DM1 mortality rate was 0.5/1,000,000 (95% CI 0.3-0.8), and standardized mortality ratio (SMR) was 5.3. A significant inverse correlation was found between age at onset of DM1 and CTG repeats (P=0.023). The cumulative probability of 15-year survival for DM1 patients in Belgrade was 49+/-5% (48+/-2% for males and 50+/-7% for females). Younger age at onset was a significant unfavorable prognostic factor (hazard ratio=4.2; P=0.012).

摘要

本研究的目的是确定1983年至2002年期间贝尔格莱德人群中1型强直性肌营养不良(DM1)患者的生存率和死亡率。收集了1983 - 2002年期间贝尔格莱德所有神经科机构医院记录中大量已诊断DM1患者的人口统计学、临床和遗传学特征数据。审查死亡证明以确定死因。采用寿命表法和Cox比例风险模型进行生存分析。在观察期内,贝尔格莱德人群中101例DM1患者中有15例出现致命结局。DM1平均死亡率为0.5/1,000,000(95%可信区间0.3 - 0.8),标准化死亡比(SMR)为5.3。发现DM1发病年龄与CTG重复序列之间存在显著负相关(P = 0.023)。贝尔格莱德DM1患者15年生存的累积概率为49±5%(男性为48±2%,女性为50±7%)。发病年龄较小是一个显著的不良预后因素(风险比 = 4.2;P = 0.012)。

相似文献

1
Survival and mortality of myotonic dystrophy type 1 (Steinert's disease) in the population of Belgrade.贝尔格莱德人群中1型强直性肌营养不良症(斯坦纳特病)的生存率和死亡率
Eur J Neurol. 2006 May;13(5):451-4. doi: 10.1111/j.1468-1331.2006.01261.x.
2
Epidemiology of myotonic dystrophy type 1 (Steinert disease) in Belgrade (Serbia).塞尔维亚贝尔格莱德1型强直性肌营养不良症(斯坦纳特病)的流行病学
Clin Neurol Neurosurg. 2006 Dec;108(8):757-60. doi: 10.1016/j.clineuro.2006.04.004. Epub 2006 May 19.
3
Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease.电生理研究与预防性起搏在伴有传导系统疾病的肌强直性营养不良成年患者中的应用及其生存率。
JAMA. 2012 Mar 28;307(12):1292-301. doi: 10.1001/jama.2012.346.
4
Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification.解析1型强直性肌营养不良的临床谱:一项基于系统登记的研究及其对疾病分类的意义。
Rev Neurol (Paris). 2016 Oct;172(10):572-580. doi: 10.1016/j.neurol.2016.08.003. Epub 2016 Sep 21.
5
Survival patterns and cancer determinants in families with myotonic dystrophy type 1.1 型肌强直性营养不良患者家系的生存模式和癌症决定因素。
Eur J Neurol. 2019 Jan;26(1):58-65. doi: 10.1111/ene.13763. Epub 2018 Sep 16.
6
Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study.1型强直性肌营养不良症的疾病认知:一项观察性横断面研究。
Orphanet J Rare Dis. 2016 Apr 4;11:34. doi: 10.1186/s13023-016-0417-z.
7
Epidemiological surveillance of myotonic dystrophy type 1: a 25-year population-based study.1 型肌强直性营养不良的流行病学监测:一项基于人群的 25 年研究。
Neuromuscul Disord. 2012 Nov;22(11):974-9. doi: 10.1016/j.nmd.2012.05.017. Epub 2012 Aug 1.
8
Hormonal and metabolic gender differences in a cohort of myotonic dystrophy type 1 subjects: a retrospective, case-control study.1 型肌强直性营养不良患者队列中的激素和代谢性别差异:回顾性病例对照研究。
J Endocrinol Invest. 2020 May;43(5):663-675. doi: 10.1007/s40618-019-01156-w. Epub 2019 Nov 30.
9
Myotonic dystrophies.强直性肌营养不良症
Chang Gung Med J. 2005 Aug;28(8):517-26.
10
On oral health in children and adults with myotonic dystrophy.关于强直性肌营养不良儿童和成人的口腔健康
Swed Dent J Suppl. 2010(203):1-51.

引用本文的文献

1
Mortality Trends and Causes of Death in Myotonic Dystrophy Type 1 Patients From the UK Clinical Practice Research Datalink.来自英国临床实践研究数据链的1型强直性肌营养不良患者的死亡率趋势和死因
Muscle Nerve. 2025 Feb;71(2):229-236. doi: 10.1002/mus.28308. Epub 2024 Dec 16.
2
Cancer and Myotonic Dystrophy.癌症与强直性肌营养不良症
J Clin Med. 2023 Mar 1;12(5):1939. doi: 10.3390/jcm12051939.
3
Frequency and type of cancers in myotonic dystrophy: A retrospective cross-sectional study.肌强直性营养不良症中的癌症发生频率和类型:一项回顾性横断面研究。
Muscle Nerve. 2023 Aug;68(2):142-148. doi: 10.1002/mus.27801. Epub 2023 Mar 27.
4
Intergenerational Influence of Gender and the DM1 Phenotype of the Transmitting Parent in Korean Myotonic Dystrophy Type 1.韩国肌强直性营养不良 1 型中传递父母的性别和 DM1 表型的代际影响。
Genes (Basel). 2022 Aug 17;13(8):1465. doi: 10.3390/genes13081465.
5
Associations Between Variant Repeat Interruptions and Clinical Outcomes in Myotonic Dystrophy Type 1.1型强直性肌营养不良症中可变重复序列中断与临床结局之间的关联
Neurol Genet. 2021 Mar 9;7(2):e572. doi: 10.1212/NXG.0000000000000572. eCollection 2021 Apr.
6
Survival patterns and cancer determinants in families with myotonic dystrophy type 1.1 型肌强直性营养不良患者家系的生存模式和癌症决定因素。
Eur J Neurol. 2019 Jan;26(1):58-65. doi: 10.1111/ene.13763. Epub 2018 Sep 16.
7
Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: A multicentre cohort follow-up study.1型强直性肌营养不良患者血浆心肌肌钙蛋白I水平升高预示左心室收缩功能障碍:一项多中心队列随访研究
PLoS One. 2017 Mar 21;12(3):e0174166. doi: 10.1371/journal.pone.0174166. eCollection 2017.
8
Hypogonadism and erectile dysfunction in myotonic dystrophy type 1.1型强直性肌营养不良症中的性腺功能减退和勃起功能障碍
Acta Myol. 2013 Oct;32(2):106-9.
9
Quantifying cancer absolute risk and cancer mortality in the presence of competing events after a myotonic dystrophy diagnosis.定量肌强直性营养不良诊断后存在竞争事件时的癌症绝对风险和癌症死亡率。
PLoS One. 2013 Nov 13;8(11):e79851. doi: 10.1371/journal.pone.0079851. eCollection 2013.
10
Molecular genetics and genetic testing in myotonic dystrophy type 1.1 型肌强直性营养不良的分子遗传学与基因检测。
Biomed Res Int. 2013;2013:391821. doi: 10.1155/2013/391821. Epub 2013 Mar 18.